相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。IGF1 receptor and thyroid-associated ophthalmopathy
Michelle Mohyi et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2018)
Evidence That Graves' Ophthalmopathy Immunoglobulins Do Not Directly Activate IGF-1 Receptors
Bernice Marcus-Samuels et al.
THYROID (2018)
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study
Elena Sabini et al.
THYROID (2018)
Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy
Giovanna Rotondo Dottore et al.
JAMA OPHTHALMOLOGY (2018)
Rehabilitative orbital decompression for Graves' orbitopathy: results of a randomized clinical trial
S. Sellari-Franceschini et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2018)
Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial
George J. Kahaly et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Teprotumumab for Thyroid-Associated Ophthalmopathy
Terry J. Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement
P. Perros et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Response to Krieger et al. re: TSHR/IGF-1R Cross-Talk, Not IGF-1R Stimulating Antibodies, Mediates Graves' Ophthalmopathy Pathogenesis'' (Thyroid 2017; 27: 746-747)
Terry J. Smith et al.
THYROID (2017)
TSHR/IGF-1R Cross-Talk, Not IGF-1R Stimulating Antibodies, Mediates Graves' Ophthalmopathy Pathogenesis
Christine C. Krieger et al.
THYROID (2017)
Teprotumumab: a new avenue for the management of moderate-to-severe and active Graves' orbitopathy?
E. Piantanida et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2017)
Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves' orbitopathy?
L. Bartalena et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2017)
TSH/IGF-1 Receptor Cross Talk in Graves' Ophthalmopathy Pathogenesis
Christine C. Krieger et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy
Luigi Bartalena et al.
EUROPEAN THYROID JOURNAL (2016)
Current Insights into the Pathogenesis of Graves' Ophthalmopathy
R. S. Bahn
HORMONE AND METABOLIC RESEARCH (2015)
Role of the Underlying Thyroid Disease on the Phenotype of Graves' Orbitopathy in a Tertiary Referral Center
Marenza Leo et al.
THYROID (2015)
Total thyroid ablation in Graves' orbitopathy
F. Menconi et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2015)
Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy
E. Sisti et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2015)
Circulating IgGs May Modulate IGF-I Receptor Stimulating Activity in a Subset of Patients With Graves' Ophthalmopathy
Aimee J. Varewijck et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Autoantibodies to the IGF1 Receptor in Graves' Orbitopathy
Waldemar B. Minich et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Thyroid Volume and Severity of Graves' Orbitopathy
Maria Antonietta Profilo et al.
THYROID (2013)
Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy
Terry J. Smith et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Outcome of Graves' Orbitopathy after Total Thyroid Ablation and Glucocorticoid Treatment: Follow-Up of a Randomized Clinical Trial
Marenza Leo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Autoimmunity in Graves' Ophthalmopathy: The Result of an Unfortunate Marriage Between TSH Receptors and IGF-1 Receptors?
Wilmar M. Wiersinga
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Exophthalmometric values and their biometric correlates: The Kandy Eye Study
WengOnn Chan et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2009)
Exophthalmometry values of Turkish adult population and the effect of age, sex, refractive status, and Hertel base values on Hertel readings
U. Beden et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2008)
Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor I receptors: A tale of two antigens implicated in Graves' disease
Shanli Tsui et al.
JOURNAL OF IMMUNOLOGY (2008)
Normal Values of Hertel Exophthalmometry in Children, Teenagers, and Adults from Tehran, Iran
Mohsen Bahmam Kashkouli et al.
OPTOMETRY AND VISION SCIENCE (2008)
Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy
Terry J. Smith et al.
THYROID (2008)
Exophthalmometric values in a normal Turkish population living in the northeastern part of Turkey
Habib Bilen et al.
THYROID (2007)
Thyrotropin receptor autoantibodies are independent risk factors for graves' ophthalmopathy and help to predict severity and outcome of the disease
Anja K. Eckstein et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway
J Pritchard et al.
JOURNAL OF IMMUNOLOGY (2003)
Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts
J Pritchard et al.
JOURNAL OF IMMUNOLOGY (2002)
分享论文
